BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17990349)

  • 1. Is there a genetic signature for liver metastasis in colorectal cancer?
    Nadal C; Maurel J; Gascon P
    World J Gastroenterol; 2007 Nov; 13(44):5832-44. PubMed ID: 17990349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.
    Bocuk D; Wolff A; Krause P; Salinas G; Bleckmann A; Hackl C; Beissbarth T; Koenig S
    BMC Cancer; 2017 May; 17(1):342. PubMed ID: 28525976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome analysis for liver metastasis gene signatures in colorectal cancer.
    Ki DH; Jeung HC; Park CH; Kang SH; Lee GY; Lee WS; Kim NK; Chung HC; Rha SY
    Int J Cancer; 2007 Nov; 121(9):2005-2012. PubMed ID: 17640062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
    Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
    J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
    Chen Y; Yu X; Xu Y; Shen H
    Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
    Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
    Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
    Macartney-Coxson DP; Hood KA; Shi HJ; Ward T; Wiles A; O'Connor R; Hall DA; Lea RA; Royds JA; Stubbs RS; Rooker S
    BMC Cancer; 2008 Jul; 8():187. PubMed ID: 18590575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of genes associated with poor prognosis of patients with colorectal cancer liver metastasis.
    Qian Z; Zhang G; Song G; Shi J; Gong L; Mou Y; Han Y
    Oncotarget; 2017 Apr; 8(15):25500-25512. PubMed ID: 28424419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
    Varghese S; Burness M; Xu H; Beresnev T; Pingpank J; Alexander HR
    Ann Surg Oncol; 2007 Dec; 14(12):3460-71. PubMed ID: 17899288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
    Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
    J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome scale map of genetic alterations promoting metastasis in colorectal cancer.
    Goryca K; Kulecka M; Paziewska A; Dabrowska M; Grzelak M; Skrzypczak M; Ginalski K; Mroz A; Rutkowski A; Paczkowska K; Mikula M; Ostrowski J
    BMC Genet; 2018 Sep; 19(1):85. PubMed ID: 30231850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
    Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
    Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Gao B; Shao Q; Choudhry H; Marcus V; Dong K; Ragoussis J; Gao ZH
    Int J Oncol; 2016 Sep; 49(3):1108-18. PubMed ID: 27571956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.